| Kalyan K. Shastri M.d. Pllc | |
|
3488 Sheridan Dr Amherst NY 14226-1545 | |
| (716) 462-4600 | |
| (716) 462-4645 |
| Full Name | Kalyan K. Shastri M.d. Pllc |
|---|---|
| Speciality | Psychiatry & Neurology |
| Location | 3488 Sheridan Dr, Amherst, New York |
| Authorized Official Name and Position | Kalyan K Shastri (OWNER) |
| Authorized Official Contact | 9724087326 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Kalyan K. Shastri M.d. Pllc Po Box 4 Getzville NY 14068-0004 Ph: (716) 462-4600 | Kalyan K. Shastri M.d. Pllc 3488 Sheridan Dr Amherst NY 14226-1545 Ph: (716) 462-4600 |
| NPI Number | 1477220770 |
|---|---|
| Provider Enumeration Date | 08/24/2021 |
| Last Update Date | 01/24/2023 |
| Certification Date | 01/24/2023 |
| Medicare PECOS PAC ID | 8820462831 |
|---|---|
| Medicare Enrollment ID | O20230314002228 |
News Archive
White matter disease covers a large group of disorders that affect the white matter, or myelin. In children these disorders are commonly genetic and often go undiagnosed. In new research, a team led by Raúl Estévez, a lecturer from the Department of Physiological Sciences II, based at the UB's Bellvitge Health Sciences Campus, working with the researcher Marjo van der Knaap, from the University Medical Centre at VU University Amsterdam, have identified mutant GLIALCAM as responsible for 25% of cases of megalencephalic leukoencephalopathy with subcortical cysts, a rare genetic disease affecting cerebral myelin.
Covidien, a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration has approved the use of molybdenum-99 derived from low-enriched uranium (LEU) in the production of technetium-99m generators.
The Council on Foreign Relations features an interview with CFR Senior Fellow for Global Health Laurie Garrett, who "notes that discovery of HIV/AIDS was the beginning of what we now consider to be global health."
Probiodrug AG announced today the transfer of its experimental cyclin-dependent kinase 9 inhibitor program to AstraZeneca. The transaction includes the sale to AstraZeneca of a lead molecule and back-up compounds with the associated intellectual property. CDK9, which has been implicated in the transcriptional regulation of genes involved in proliferation and inflammation, is a promising target for the treatment of both cancer and inflammatory diseases.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477220770 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084D0003X | Psychiatry & Neurology - Diagnostic Neuroimaging | (* (Not Available)) | Secondary |
| 2084N0400X | Psychiatry & Neurology - Neurology | (* (Not Available)) | Primary |
| Provider Name | Amy L Heyden |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1952633059 PECOS PAC ID: 3476722505 Enrollment ID: I20110808000168 |
News Archive
White matter disease covers a large group of disorders that affect the white matter, or myelin. In children these disorders are commonly genetic and often go undiagnosed. In new research, a team led by Raúl Estévez, a lecturer from the Department of Physiological Sciences II, based at the UB's Bellvitge Health Sciences Campus, working with the researcher Marjo van der Knaap, from the University Medical Centre at VU University Amsterdam, have identified mutant GLIALCAM as responsible for 25% of cases of megalencephalic leukoencephalopathy with subcortical cysts, a rare genetic disease affecting cerebral myelin.
Covidien, a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration has approved the use of molybdenum-99 derived from low-enriched uranium (LEU) in the production of technetium-99m generators.
The Council on Foreign Relations features an interview with CFR Senior Fellow for Global Health Laurie Garrett, who "notes that discovery of HIV/AIDS was the beginning of what we now consider to be global health."
Probiodrug AG announced today the transfer of its experimental cyclin-dependent kinase 9 inhibitor program to AstraZeneca. The transaction includes the sale to AstraZeneca of a lead molecule and back-up compounds with the associated intellectual property. CDK9, which has been implicated in the transcriptional regulation of genes involved in proliferation and inflammation, is a promising target for the treatment of both cancer and inflammatory diseases.
› Verified 9 days ago
| Provider Name | Kalyan K Shastri |
|---|---|
| Provider Type | Practitioner - Neurology |
| Provider Identifiers | NPI Number: 1275794554 PECOS PAC ID: 4486808136 Enrollment ID: I20130204000481 |
News Archive
White matter disease covers a large group of disorders that affect the white matter, or myelin. In children these disorders are commonly genetic and often go undiagnosed. In new research, a team led by Raúl Estévez, a lecturer from the Department of Physiological Sciences II, based at the UB's Bellvitge Health Sciences Campus, working with the researcher Marjo van der Knaap, from the University Medical Centre at VU University Amsterdam, have identified mutant GLIALCAM as responsible for 25% of cases of megalencephalic leukoencephalopathy with subcortical cysts, a rare genetic disease affecting cerebral myelin.
Covidien, a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration has approved the use of molybdenum-99 derived from low-enriched uranium (LEU) in the production of technetium-99m generators.
The Council on Foreign Relations features an interview with CFR Senior Fellow for Global Health Laurie Garrett, who "notes that discovery of HIV/AIDS was the beginning of what we now consider to be global health."
Probiodrug AG announced today the transfer of its experimental cyclin-dependent kinase 9 inhibitor program to AstraZeneca. The transaction includes the sale to AstraZeneca of a lead molecule and back-up compounds with the associated intellectual property. CDK9, which has been implicated in the transcriptional regulation of genes involved in proliferation and inflammation, is a promising target for the treatment of both cancer and inflammatory diseases.
› Verified 9 days ago
| Provider Name | Syntyia L Taylor |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1215408372 PECOS PAC ID: 8123366556 Enrollment ID: I20190211001670 |
News Archive
White matter disease covers a large group of disorders that affect the white matter, or myelin. In children these disorders are commonly genetic and often go undiagnosed. In new research, a team led by Raúl Estévez, a lecturer from the Department of Physiological Sciences II, based at the UB's Bellvitge Health Sciences Campus, working with the researcher Marjo van der Knaap, from the University Medical Centre at VU University Amsterdam, have identified mutant GLIALCAM as responsible for 25% of cases of megalencephalic leukoencephalopathy with subcortical cysts, a rare genetic disease affecting cerebral myelin.
Covidien, a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration has approved the use of molybdenum-99 derived from low-enriched uranium (LEU) in the production of technetium-99m generators.
The Council on Foreign Relations features an interview with CFR Senior Fellow for Global Health Laurie Garrett, who "notes that discovery of HIV/AIDS was the beginning of what we now consider to be global health."
Probiodrug AG announced today the transfer of its experimental cyclin-dependent kinase 9 inhibitor program to AstraZeneca. The transaction includes the sale to AstraZeneca of a lead molecule and back-up compounds with the associated intellectual property. CDK9, which has been implicated in the transcriptional regulation of genes involved in proliferation and inflammation, is a promising target for the treatment of both cancer and inflammatory diseases.
› Verified 9 days ago
News Archive
White matter disease covers a large group of disorders that affect the white matter, or myelin. In children these disorders are commonly genetic and often go undiagnosed. In new research, a team led by Raúl Estévez, a lecturer from the Department of Physiological Sciences II, based at the UB's Bellvitge Health Sciences Campus, working with the researcher Marjo van der Knaap, from the University Medical Centre at VU University Amsterdam, have identified mutant GLIALCAM as responsible for 25% of cases of megalencephalic leukoencephalopathy with subcortical cysts, a rare genetic disease affecting cerebral myelin.
Covidien, a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration has approved the use of molybdenum-99 derived from low-enriched uranium (LEU) in the production of technetium-99m generators.
The Council on Foreign Relations features an interview with CFR Senior Fellow for Global Health Laurie Garrett, who "notes that discovery of HIV/AIDS was the beginning of what we now consider to be global health."
Probiodrug AG announced today the transfer of its experimental cyclin-dependent kinase 9 inhibitor program to AstraZeneca. The transaction includes the sale to AstraZeneca of a lead molecule and back-up compounds with the associated intellectual property. CDK9, which has been implicated in the transcriptional regulation of genes involved in proliferation and inflammation, is a promising target for the treatment of both cancer and inflammatory diseases.
› Verified 9 days ago
Anthony F Bongiovanni Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 315 Alberta Dr Ste 211, Amherst, NY 14226 Phone: 716-837-6705 Fax: 716-837-6759 | |
Ofer Ziv, Lcsw, Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1416 Sweet Home Rd Ste 1, Amherst, NY 14228 Phone: 716-800-1178 Fax: 716-745-8070 | |
Ordinary Mind Mental Health Counseling Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1408 Sweet Home Rd Ste 1, Amherst, NY 14228 Phone: 716-830-7474 Fax: 716-259-1306 | |
E. Glynn Couch Lcsw, Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 331 Alberta Dr Ste 104, Amherst, NY 14226 Phone: 716-783-4591 | |
Anne W Murray Lcsw Pllc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 4511 Harlem Rd Rm 1, Amherst, NY 14226 Phone: 716-861-5928 Fax: 716-877-4894 | |
Beacon Center Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 3354 Sheridan Dr, Amherst, NY 14226 Phone: 716-831-1937 Fax: 716-831-8837 | |
Wny Peaceful Warrior Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 6225 Sheridan Dr Ste 110, Amherst, NY 14221 Phone: 585-301-2983 |